公司概覽
業務類別 Diagnostics & Research
業務概覽 Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ inthe office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
公司地址 One IDEXX Drive, Westbrook, ME, USA, 04092
電話號碼 +1 207 556-0300
傳真號碼 +1 207 556-4346
公司網頁 https://www.idexx.com
員工數量 11000
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Dr. Michael G. Erickson, PhD Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine -- 13/01/2026
Mr. Andrew J. Emerson Executive Vice President, Chief Financial Officer, Treasurer and Principal Accounting Officer 美元 531.15K 27/03/2026
Mr. George J. Fennell Executive Vice President, Global CAG Commercial -- 27/03/2026
Mr. Jonathan J. Mazelsky Director, President and Chief Executive Officer 美元 1.15M 13/01/2026
Dr. Martin Alexander Smith, PhD Executive Vice President, Global Operations and Research and Development 美元 594.05K 27/03/2026
Ms. Sharon E. Underberg Executive Vice President, General Counsel and Corporate Secretary -- 27/03/2026
Mr. Michael J. Lane Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology 美元 594.05K 27/03/2026
Mr. Michael Schreck Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience -- 27/03/2026
Mr. Michael P. Johnson Senior Vice President and Chief Human Resources Officer -- 27/03/2026
 
董事會成員
董事會 職務 更新日期
Mr. Bruce L. Claflin Independent Director 27/03/2026
Mr. Daniel M. Junius Independent Director 27/03/2026
Ms. M. Anne Szostak Independent Director 13/02/2026
Mr. Lawrence D. Kingsley Non-Executive Chairman of the Board 27/03/2026
Dr. Sophie V. Vandebroek, PhD Independent Director 27/03/2026
Mr. Stuart M. Essig, PhD Independent Director 27/03/2026
Mr. Jonathan J. Mazelsky Director, President and Chief Executive Officer 13/01/2026
Mr. Sam A. Samad Independent Director 27/03/2026
Mr. Joseph L. Hooley Lead Independent Director 27/03/2026
Ms. Karen A. Peacock Independent Director 27/03/2026
Ms. Irene Chang Britt Independent Director 27/03/2026
 
所屬ETF (更新日期: 02/05/2026 04:29)
代號 名稱 佔比% 持有日期
HCMTDirexion HCM Tactical EnhU.S.EqStratETF0.0004%29/04/2026
TUGSTF Tactical Growth ETF0.0003%29/04/2026
SPUUDirexion Daily S&P 500® Bull 2X ETF0.0003%29/04/2026
TOVJLens 500 Jewish Advocacy U.S. ETF0.0003%29/04/2026
QWLDState Street® SPDR® MSCI Wld StrtFcs ETF0.0003%29/04/2026
BMEDiShares Health Innovation Active ETF0.0003%29/04/2026
XMAGDefiance Large Cap ex-Mag 7 ETF0.0003%29/04/2026
GSPYGotham Enhanced 500 ETF0.0003%29/04/2026
PQUSPictet AI Enhanced US Equity ETF0.0003%29/04/2026
PRXGPraxis Impact Large Cap Growth ETF0.0003%29/04/2026
NZACState Street®SPDR®MSCIACWIClmPrsAlgndETF0.0003%27/04/2026
GLOFiShares Global Equity Factor ETF0.0003%28/04/2026
STXGStrive 1000 Growth ETF0.0003%29/04/2026
TOKiShares MSCI Kokusai ETF0.0003%28/04/2026
PCGGPolen Capital Global Growth ETF0.0003%31/03/2026
IQMFranklin Intelligent Machines ETF0.0003%29/04/2026
ACGRAmerican Century Large Cap Growth ETF0.0003%31/03/2026
ESGFlexShares STOXX US ESG Select ETF0.0003%29/04/2026
NXTISimplify Next Intangible Core Index ETF0.0003%29/04/2026
IALTiShares Systematic Alternatives Actv ETF0.0002%28/04/2026
  1    2    3    4    5    6    7    8    9    10    11    12   13    14    15    16    17    18    19  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.